Immatics IMTX
NASDAQ IMTX
$7.59 -0.85 (-10.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immatics (IMTX) Non-Interest Income (2023 - 2026)

Updated

Immatics (IMTX) recorded Non-Interest Income of -$72.96 million in Q2 2026, compared with -$80.77 million a year earlier.

Analysis

Immatics (IMTX) Non-Interest Income (2023 - 2026) Analysis & Trends

On a TTM basis, Immatics' Non-Interest Income came in at -$280.59 million as of Jun 30, 2026.

  • Quarterly Non-Interest Income has ranged from -$80.77 million in Q2 2025 to -$1.87 million in Q1 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Interest Income (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Immatics 1.13 Bn -906.67 Mn - -72.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.96 Mn
Mar 31, 2026 -67.62 Mn
Sep 30, 2025 -59.24 Mn
Jun 30, 2025 -80.77 Mn
Mar 31, 2025 -42.97 Mn
Sep 30, 2024 -2.58 Mn
Jun 30, 2024 -19.22 Mn
Mar 31, 2024 -1.87 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 -26.80 Mn
Mar 31, 2023 -21.20 Mn
API Access

Immatics Non-Interest Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-interest-income&ticker=IMTX&period=max&api_key=YOUR_API_KEY